Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos

  1. Amanda D Yzaguirre
  2. Arun Padmanabhan
  3. Eric D de Groh
  4. Kurt A Engleka
  5. Jun Li
  6. Nancy A Speck
  7. Jonathan A Epstein  Is a corresponding author
  1. University of Pennsylvania, United States
  2. Harvard Medical School, United States
  3. Medpace Inc., United States

Abstract

Type I Neurofibromatosis (NF1) is caused by mutations in the NF1 gene encoding neurofibromin. Neurofibromin exhibits Ras GTPase activating protein (Ras-GAP) activity that is thought to mediate cellular functions relevant to disease phenotypes. Loss of murine Nf1 results in embryonic lethality due to heart defects, while mice with monoallelic loss of function mutations, or with tissue-specific inactivation have been used to model NF1. Here, we characterize previously unappreciated phenotypes in Nf1-/- embryos, which are inhibition of hemogenic endothelial specification in the dorsal aorta, enhanced yolk sac hematopoiesis, and exuberant cardiac blood island formation. We show that a missense mutation engineered into the active site of the Ras-GAP domain is sufficient to reproduce ectopic blood island formation, cardiac defects and overgrowth of neural crest-derived structures seen in Nf1-/- embryos. These findings demonstrate a role for Ras-GAP activity in suppressing hemogenic potential of the heart, and restricting growth of neural crest-derived tissues.

Article and author information

Author details

  1. Amanda D Yzaguirre

    Abramson Family Cancer Research Institute, Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine at the University of Pennsylvania, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Arun Padmanabhan

    Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Eric D de Groh

    Medpace Inc., Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Kurt A Engleka

    Cardiovascular Institute, Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine at the University of Pennsylvania, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Jun Li

    Cardiovascular Institute, Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine at the University of Pennsylvania, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Nancy A Speck

    Abramson Family Cancer Research Institute, Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine at the University of Pennsylvania, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Jonathan A Epstein

    Cardiovascular Institute, Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine at the University of Pennsylvania, University of Pennsylvania, Philadelphia, United States
    For correspondence
    epsteinj@upenn.edu
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Kevin Shannon, University of California, San Francisco, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations inthe Guide for the Care and Use of Laboratory Animals of the NationalInstitutes of Health. All of the animals were handled according toapproved institutional animal care and use committee (IACUC) protocols(#803789 and #803317) of the University of Pennsylvania.

Version history

  1. Received: March 30, 2015
  2. Accepted: October 12, 2015
  3. Accepted Manuscript published: October 13, 2015 (version 1)
  4. Version of Record published: December 8, 2015 (version 2)

Copyright

© 2015, Yzaguirre et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,989
    Page views
  • 348
    Downloads
  • 14
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Amanda D Yzaguirre
  2. Arun Padmanabhan
  3. Eric D de Groh
  4. Kurt A Engleka
  5. Jun Li
  6. Nancy A Speck
  7. Jonathan A Epstein
(2015)
Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos
eLife 4:e07780.
https://doi.org/10.7554/eLife.07780

Share this article

https://doi.org/10.7554/eLife.07780

Further reading

    1. Cell Biology
    Wan-ping Yang, Mei-qi Li ... Qian-qian Luo
    Research Article

    High-altitude polycythemia (HAPC) affects individuals living at high altitudes, characterized by increased red blood cells (RBCs) production in response to hypoxic conditions. The exact mechanisms behind HAPC are not fully understood. We utilized a mouse model exposed to hypobaric hypoxia (HH), replicating the environmental conditions experienced at 6000 m above sea level, coupled with in vitro analysis of primary splenic macrophages under 1% O2 to investigate these mechanisms. Our findings indicate that HH significantly boosts erythropoiesis, leading to erythrocytosis and splenic changes, including initial contraction to splenomegaly over 14 days. A notable decrease in red pulp macrophages (RPMs) in the spleen, essential for RBCs processing, was observed, correlating with increased iron release and signs of ferroptosis. Prolonged exposure to hypoxia further exacerbated these effects, mirrored in human peripheral blood mononuclear cells. Single-cell sequencing showed a marked reduction in macrophage populations, affecting the spleen’s ability to clear RBCs and contributing to splenomegaly. Our findings suggest splenic ferroptosis contributes to decreased RPMs, affecting erythrophagocytosis and potentially fostering continuous RBCs production in HAPC. These insights could guide the development of targeted therapies for HAPC, emphasizing the importance of splenic macrophages in disease pathology.

    1. Cell Biology
    Jurgen Denecke
    Insight

    Mapping proteins in and associated with the Golgi apparatus reveals how this cellular compartment emerges in budding yeast and progresses over time.